
Overview
Dr. Maranchie is a surgical oncologist specializing in urologic cancers of the urinary tract and male genitalia. She completed urology residency at Harvard University in 1999, followed by a fellowship in Urologic Oncology at the National Cancer Institute. Her practice is focused on the care of patients with cancer of the kidney, bladder and testis, employing minimally invasive approaches, nephron-sparing and nerve-sparing surgery and urinary tract reconstruction. She has specialty expertise in familial or inherited cancer syndromes, offering targeted surveillance with organ-preserving surgery when indicated. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling.
Dr. Maranchie is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. Her top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy.
Her clinical research consists of co-authoring 65 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5200 Centre Avenue, Suite 209, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
UPMC Department Of Urology
Quoc-Dien Trinh, MD, MBA, serves as the Chair of the Department of Urology, University of Pittsburgh School of Medicine, and Chair of Urology, UPMC. A globally recognized urological surgeon-scientist, Dr. Trinh has been honored with the 2021 Outstanding Citizenship Award from Brigham and Women’s Hospital and the 2022 American Urological Association Young Urologist of the Year award for New England. He is recognized as a Castle Connolly Top Doctor and a Top Asian American Pacific Islander Doctor. Dr. Trinh is rated as an Elite provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Prostate Cancer, Bladder Cancer, Urothelial Cancer, Prostatectomy, and Cystectomy.
UPMC Department Of Urology
Paul Rusilko, MD is an Associate Professor in the Departments of Urology and Plastic Surgery at the University of Pittsburgh School of Medicine, serving as the Director of Reconstructive Urology and the Associate Residency Program Director for the urology residency program. He is board-certified by the American Board of Urology. He specializes in reconstructive and trauma surgery of the genitourinary system. Complex urologic procedures performed include urethral reconstruction, urethroplasty, adult acquired buried penis, urologic prosthetics for both erectile dysfunction and urinary incontinence, Peyronie’s disease, and genital reconstruction following trauma and penile cancer. Dr. Rusilko is rated as a Distinguished provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Urethral Stricture, Neurogenic Bladder, Perirenal Abscess, Penectomy, and Reconstructive Urology Surgery.
University Of Pittsburgh Physicians, Department Of Urology
Dr. Michael C. Ost is a urologist who treats a wide array of urologic conditions in both adults and children. He is skilled in minimally invasive surgery, utilizing robotics, laparoscopy, and endourologic techniques. His areas of expertise include the treatment of kidney cancer, congenital renal anomalies, ureteral injuries and abnormalities, and complex stone disease. Dr. Ost received his medical degree from the Mount Sinai School of Medicine in New York City. He received subspecialty fellowship training in both endourology (Northwell Health System – New York) and pediatric urology (UPMC Children’s Hospital of Pittsburgh). He was the first urologist in the United States to receive such training to treat a wide spectrum of urologic diseases in a minimally invasive fashion in both adults and children. He is widely published and has lectured nationally and internationally on his areas of specialization. Dr. Ost also received his MBA from the Ross School of Business at the University of Michigan. In addition to his clinical practice as a professor of urology, Dr. Ost serves as Director of Pediatric Surgical Outreach at UPMC Children’s Hospital of Pittsburgh and Assistant Dean for Interprofessional Education and Technology at the University of Pittsburgh School of Medicine. Dr. Ost is rated as a Distinguished provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Anorchia, Ureterocele, UPJ Obstruction, Lithotripsy, and Ureteroscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder CancerDr. Maranchie isDistinguished. Learn about Bladder Cancer.
- Muscle Invasive Bladder CancerDr. Maranchie isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Maranchie isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Renal Cell Carcinoma (RCC)Dr. Maranchie isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerDr. Maranchie isDistinguished. Learn about Urothelial Cancer.
- Von Hippel-Lindau (VHL) SyndromeDr. Maranchie isDistinguished. Learn about Von Hippel-Lindau (VHL) Syndrome.
- Advanced
- Bilateral HydronephrosisDr. Maranchie isAdvanced. Learn about Bilateral Hydronephrosis.
- Chromophobe Renal Cell CarcinomaDr. Maranchie isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Maranchie isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Maranchie isAdvanced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Maranchie isAdvanced. Learn about Familial Wilms Tumor 2.
- HydronephrosisDr. Maranchie isAdvanced. Learn about Hydronephrosis.
- Experienced
- BoilsDr. Maranchie isExperienced. Learn about Boils.
- CarbuncleDr. Maranchie isExperienced. Learn about Carbuncle.
- ChoriocarcinomaDr. Maranchie isExperienced. Learn about Choriocarcinoma.
- Cowden SyndromeDr. Maranchie isExperienced. Learn about Cowden Syndrome.
- CystectomyDr. Maranchie isExperienced. Learn about Cystectomy.
- EmpyemaDr. Maranchie isExperienced. Learn about Empyema.


